About Sarah Kim
Sarah Kim, Ph.D. is a Research Assistant Professor in the Department of Pharmaceutics at the University of Florida. She is a practicing pharmacometrician with a background in Applied Mathematics. As an early-stage Principal Investigator, she is leading several funded computational modeling projects to create and innovate quantitative solutions in healthcare. The shared goal of these proejcts is to develop model-based clinical trial simulation tools, which will help drug developers optimize clinical trial designs.
She graduated summa cum laude with the President’s honor with a Bachelor’s degree in 2008, and completed her Master’s degree in 2010 both in Applied Mathematics from Hanyang University, South Korea. She earned her doctorate in Biomathematics at Florida State University in 2015. She has received several awards including David Goldstein and Presidential Trainee Awards from the American Society for Clinical Pharmacology and Therapeutics.
Dr. Kim’s current research focuses on:
(1) Mathematical modeling and simulations informing experimental designs to examine combinations of anti-Mycobacterium tuberculosis agents to identify optimal regimens which markedly shorten the length of tuberculosis treatments and prevent the emergence of resistance.
(2) Developing a disease progression model-based clinical trial simulation (CTS) tool designed to optimize clinical trial enrichment and design of studies to investigate the efficacy of potential therapies for Duchenne Muscular Dystrophy.
(3) Developing a disease progression model-based CTS tool designed to inform optimizing clinical trial designs for Type 1 Diabetes prevention studies.